8
Oct
2024

Sever Pharma Solutions

Exhibitor at CPHI Milan 2024 stand 5A147, Contract Manufacturing and Services
About Us

CONSULT OUR EXPERTS AT CPHI 2023

Sever Pharma Solutions is one of a few CDMOs specializing in controlled release systems for highly potent drugs and offering end-to-end services.

We can develop new products throughout the different stages of development and manufacture commercial products. We can enhance your complex pharmaceutical product by adding our high-potent drug development expertise, global GMP compliance, core capabilities, and commitment to delivering results.

Book a meeting

At CPHI, you can benefit from the expertise of our experienced and knowledgeable scientists. Whether you want to discuss Hot Melt Extrusion, Polymer-based delivery systems and High-potent dosage forms, they are ready to consult you on how to make your project come alive in the best way possible.

Book a meeting by clicking the “Book a meeting” button further down on this side.

  • SE
  • 2023
    On CPHI since
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 5A147, Contract Manufacturing and Services

Products Featured at CPHI Milan 2024

  • Aseptic fill and finish

    Product Aseptic fill and finish

    We offer solutions for companies that need CMO capacity concerning the aseptic filling of syringes and assembly and packaging of pre-filled syringes and auto-injectors. We will enhance your product by adding value through manufacturing if you require additional capacity or a complete technology transfer. q...
  • High-potent Dosage Forms

    Product High-potent Dosage Forms

    We have the experience, expertise, and facilities at Sever Pharma Solutions to safely work with your high-potent substances. This includes manufacturing products containing APIs that are ranked in the highest occupational exposure bands (OEB) up to and including OEB6.

    Our focus on safety starts ...
  • Hot Melt Extrusion

    Product Hot Melt Extrusion

    To successfully develop and manufacture your polymer-based delivery systems, like implants and intra-vaginal rings, we have advanced extrusion capabilities in Malmö (Sweden) and Putnam (US Connecticut). The US site is also a center of expertise for Hot Melt Extrusion (HME).

    HME improves the bioa...
  • Polymer-based delivery systems

    Product Polymer-based delivery systems

    Polymer-based dosage forms continuously administer the drug to the patient for an extended period, varying from weeks to years. These controlled-release products are very suitable for specific indications, patient populations, and drugs due to the long duration of action, avoidance of first-pass metabolism...

Sever Pharma Solutions Resources (2)

  • Whitepaper A COMPARISON OF SATURATED SOLUBILITY ENHANCEMENT VIA SPRAY DRYING AND HOT MELT EXTRUSION PROCESSING

    Solid solutions are similar to liquid solutions and consist of a single phase irrespective of the number of components. A solid solution of a poorly water-soluble drug dissolved in a carrier is particularly interesting in improving oral bioavailability. In a solid solution, the drug’s particle size has been reduced to its molecular dimensions resulting in a more rapid dissolution rate. By judicious selection of a carrier, the dissolution rate of the drug can be increased by up to several orders of magnitude. In a solid solution, the drug’s particle size has been reduced to its molecular dimensions resulting in a more rapid dissolution rate.

    This whitepaper compares solubility enhancement between spray drying and hot melt extrusion for a poorly soluble, new active pharmaceutical ingredient.

  • Whitepaper ANALYTICAL TOOLS & TECHNIQUES IN HOT MELT EXTRUSION - CASE STUDY ON PROCESS SCALE UP

    Hot melt extrusion has been widely used as a processing method for many purposes, including forming a solid molecular dispersion to increase the bioavailability of poorly soluble drugs. Analytical tools and techniques can significantly reduce time and improve success rates in developing hot melt extrusion formulations.

    In the scale-up phase, analytical characterization techniques ensure similar solubility enhancement occurs on larger extrusion equipment as with the lab scale equipment used for formulation development.

    In this whitepaper, you will learn more about the analytical characterization and techniques that are critical in the scale-up of melt-extruded solid dispersions to ensure similar products are produced, specifically in obtaining similar solubility-enhancing effects.